Articles & insights
Regulatory Updates & Compliance News
New guidance, legislation and developments affecting pharmaceutical compliance.
PMCPA’s 2026 Social Media Guidance: Compliance Priorities Companies Should Address Now
What the PMCPA's 2026 Social Media Guidance means for pharma: employee activity, corporate accounts, influencers and adverse event monitoring.
Read the article 2026-04-30Navigating Country-Level Accountability in Europe: A Key Pillar of Healthcare Compliance
How legal representative and national compliance roles differ across Spain, France and Germany, and how to fit them into your global governance.
Read the article 2026-02-23Sunshine Act in France: Understanding the Transparency in Healthcare System
The French Sunshine Act (Loi Bertrand) explained: who must report, what is published on Transparence Santé, timelines, penalties and EFPIA differences.
Read the article 2025-09-04AI in Healthcare Compliance: Navigating Opportunities, Risks, and Regulatory Landscapes
How AI supports pharma compliance audits, material review and regulatory monitoring, the risks of bias and over-reliance, and what the EU AI Act means.
Read the article 2025-05-05The Future of Diversity & Inclusion in Pharma Compliance: A European Perspective
Diversity and inclusion in pharma compliance from a European perspective: why DEI remains a compliance matter and how to embed it in governance.
Read the articleQuestions, answered
Regulatory Updates & Compliance News: common questions
What is the UK failure to prevent fraud offence?
A corporate offence introduced by the Economic Crime and Corporate Transparency Act 2023, which has applied since 1 September 2025.
Which EU regulation governs AI?
Regulation (EU) 2024/1689, the EU AI Act, read alongside the GDPR, the EU Data Act and, where AI forms part of a medical device or diagnostic, the MDR and IVDR.